HTA topics

Each year, the Federal Medical Services Commission (ELGK) and the Federal Medicines Commission (EAK) select – from the proposals submitted – the topics which are to be included in the HTA programme. In addition, the HTA programme can take up topics that are brought forward by the FOPH internally. Below all topics are listed by year.

Topics selected in 2020

  • Migraine prophylaxis
  • Glucocorticosteroids in osteoarthritis
  • Antidepressants for depression
  • Oral anticoagulants for atrial fibrillation
  • Coronary angiography in coronary artery disease
  • Therapy duration of Trastuzumab in early-stage HER2-positive breast cancer
  • Point-of-care diagnostic tests
  • Invasive procedures in coronary artery disease

Topics selected in 2019

  • Medicines for Alzheimer’s disease/dementia
  • Infliximab biosimilars in rheumatoid arthritis
  • Palbociclib for HR+/HER2- advanced breast cancer
  • Denosumab in osteoporosis
  • Sedatives and sleeping pills for anxiety and sleep disorders
  • Vitamin B12 testing for suspected vitamin B12 deficiency
  • Levothyroxine in elderly patients with subclinical hypothyroidism
  • Folic acid tests for suspected folic acid deficiency
  • Thyroid hormone tests for the diagnosis of primary hypo- or hyperthyroidism
  • Long-term physiotherapy for multiple sclerosis / Parkinson’s disease / hemiplegia
  • Dosage interval of zoledronate in bone metastases of solid tumours and in multiple myeloma

Topics selected in 2018

  • Cholesterol-lowering agents
  • The treatment of primary hypercholesterolemia with ezetimibe-containing medicines
  • Surgical treatment of osteoporotic vertebral body fractures by vertebroplasty and kyphoplasty
  • Surgical intervention in shoulder impingement syndrome
  • Glitazones in type 2 diabetes
  • Glinides in type 2 diabetes
  • Dual platelet inhibition following coronary implantation of drug-coated stents

Topics selected in 2017

  • Mono and combination therapies with olmesartan
  • Vitamin D tests
  • Proton-pump inhibitors (PPIs) for patients with non-erosive gastroesophageal reflux disease and non-endoscopic reflux disease

Topics selected in 2016

  • Self-measurement of blood glucose for patients with non-insulin-dependent (Type 2) diabetes
  • Use of drugs containing chondroitin sulfate in the treatment of osteoarthritis
  • Removal of osteosynthesis materials (e.g. screws, plates, nails and wires) used to treat bone fractures

Topics selected in 2015

  • Knee arthroscopy
  • Spinal procedures involving different implants
  • Iron therapy for iron deficiency without anaemia

Last modification 30.03.2021

Top of page

Contact

Federal Office of Public Health FOPH
Health insurance benefits Division
Health Technology Assessment Section
Schwarzenburgstrasse 157
3003 Berne
Switzerland
Tel. +41 58 469 17 33
E-mail

Print contact

https://www.bag.admin.ch/content/bag/en/home/versicherungen/krankenversicherung/krankenversicherung-bezeichnung-der-leistungen/re-evaluation-hta/scoping-berichte.html